RNA interference in adult Ascaris suum – an opportunity for the development of a functional genomics platform that supports organism-, tissue- and cell-based biology in a nematode parasite  by McCoy, Ciaran J. et al.
International Journal for Parasitology 45 (2015) 673–678Contents lists available at ScienceDirect
International Journal for Parasitology
journal homepage: www.elsevier .com/locate / i jparaSuccinctusRNA interference in adult Ascaris suum – an opportunity for the
development of a functional genomics platform that supports organism-,
tissue- and cell-based biology in a nematode parasitehttp://dx.doi.org/10.1016/j.ijpara.2015.05.003
0020-7519/ 2015 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
⇑ Corresponding author.
E-mail address: a.mousley@qub.ac.uk (A. Mousley).Ciaran J. McCoy a, Neil D. Warnock a, Louise E. Atkinson a, Erwan Atcheson a, Richard J. Martin b,
Alan P. Robertson b, Aaron G. Maule a, Nikki J. Marks a, Angela Mousley a,⇑
a Parasitology, Institute for Global Food Security, School of Biological Sciences, Queen’s University Belfast, Belfast BT9 7BL, UK
bDepartment of Biomedical Sciences, Iowa State University, Ames, IA 50011, USA
a r t i c l e i n f o a b s t r a c tArticle history:
Received 3 April 2015
Received in revised form 19 May 2015
Accepted 22 May 2015





Reverse geneticsThe sustainable control of animal parasitic nematodes requires the development of efﬁcient functional
genomics platforms to facilitate target validation and enhance anthelmintic discovery. Unfortunately,
the utility of RNA interference (RNAi) for the validation of novel drug targets in nematode parasites
remains problematic. Ascaris suum is an important veterinary parasite and a zoonotic pathogen. Here
we show that adult A. suum is RNAi competent, and highlight the induction, spread and consistency of
RNAi across multiple tissue types. This platform provides a new opportunity to undertake whole
organism-, tissue- and cell-level gene function studies to enhance target validation processes for nema-
tode parasites of veterinary/medical signiﬁcance.
 2015 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Nematode parasites are a major cause of disease in humans and
animals where they undermine health and global food security.
Over one billion people living in the developing areas of
sub-Saharan Africa, Asia and the Americas are infected with at least
one nematode parasite (see Lustigman et al., 2012), and the world-
wide economic impact of nematode parasites to the livestock
industry is estimated to be >GBP 10 billion per annum (Roeber
et al., 2013). Ascaris suum is a gastrointestinal parasite of pigs
which impacts signiﬁcantly on pig health through reductions in
ﬁnishing weights, feed conversion efﬁciencies and carcass quality.
Recent publications have highlighted the zoonotic potential of A.
suum and there is now evidence to suggest that A. suum is more
than a close relative of the human pathogen, Ascaris lumbricoides
(see Peng and Criscione, 2012). This is signiﬁcant given that more
than one billion people worldwide suffer from ascariasis and its
resultant chronic morbidity (see Lustigman et al., 2012).
In the absence of viable, commercially available vaccines, the
control of nematode parasites relies heavily on a small collection
of chemotherapeutic drugs in both human and veterinary medicine
(see Prichard et al., 2012). Signiﬁcantly, multi-drug resistance has
been reported in many of the key parasitic nematodes of livestock(see Kaplan, 2004) and drug resistance in human therapy is a rising
concern (see Prichard et al., 2012).
Our future defence against nematode parasites in both humans
and livestock is dependent on the identiﬁcation and validation of
novel chemotherapeutic targets. The availability of genomic and
transcriptomic sequence data for nematodes is rapidly progress-
ing; 25 published genomes and P100 signiﬁcant transcriptomic
datasets are now available for mining (Blaxter and Koutsovoulos,
2014; Cotton et al., 2014; Foth et al., 2014; Jex et al., 2014;
Rödelsperger et al., 2014; Tang et al., 2014). Genome-directed drug
discovery has made signiﬁcant inroads towards the identiﬁcation
of putative novel drug targets for nematode pathogens but valida-
tion will require the incorporation of functional tools in therapeu-
tically relevant parasite species.
RNA interference (RNAi) is an appealing reverse genetics tool
and, whilst its utility for the validation of drug targets in veterinary
parasites is widely accepted, issues with their variable sensitivity
to standard RNAi approaches have undermined the development
of robust gene silencing platforms (see Maule et al., 2011).
Although successful RNAi has been reported in 11 animal para-
sitic nematode (APN) species (see Maule et al., 2011; Tzelos
et al., 2013), the utility of these data is hampered by a variety of
species/tissue/target-speciﬁc inconsistencies in RNAi responsive-
ness. A key hurdle to the exploitation of putative targets identiﬁed
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of target function in relevant parasites.
Importantly, the adult stage of A. suum is well established as a
parasite model system and more is known about the basic biology
of A. suum than any other veterinary parasite. Amongst nematode
parasites, A. suum has the most genomic/transcriptomic resources
and it offers unrivalled utility for cell biology/physiology/biochem
istry studies (Jex et al., 2011), supported by an extensive array of
physiology- and cell-based assays for functional studies (Stretton
and Maule, 2013). The tractability of A. suum as an experimental
model makes the application of RNAi to the adult stage very
appealing. To date, only larval stage A. suum have been shown to
be RNAi susceptible (Islam et al., 2005; Xu et al., 2010; Chen
et al., 2011).
Here we describe the development of an RNAi platform in adult
A. suum that has the potential to signiﬁcantly advance drug target
validation in nematode parasites. Our data demonstrate that: (i)
RNAi is readily achievable in adult A. suum. We have developed a
method for the induction of RNAi in adult A. suum through the
injection of double-stranded RNA (dsRNA) (100 ll; 200 ng/ll) into
the pseudocoelomic cavity of female worms (see Fig. 1A). Adult A.
suum were collected from the abattoir and transferred to the labo-
ratory in mammal saline (0.9% NaCl). Worms were maintained in
Ascaris Ringers Solution (ARS: 13.14 mM NaCl, 9.47 mM CaCl2,7.83 mM MgCl2, 12.09 mM C4H11NO3/ Tris, 99.96 mM NaC2H3O2,
19.64 mM KCl, pH 7.8) for a maximum of 24 h prior to use, and
for the duration of the RNAi experiments (for speciﬁc methodology
see Fig. 1).
We have achieved target transcript knockdown that: (a) is
robust (e.g. P60.0% (P < 0.05) knockdown across multiple targets
(A. suum elongation factor 1a (As-eft-1); Elongation factor 1b
(As-eft-2); GMP reductase (As-gmpr), troponin C (As-tnc-1),
Ras-related protein (As-rab-3), haemoglobin (As-hb-1), and two
nicotinic acetylcholine receptor subunits (As-unc-29 and
As-unc-38)) atP3 days post-RNAi trigger delivery; (b) occurs rela-
tively quickly (signiﬁcant transcript knockdown recorded as early
as 24 h post-RNAi trigger delivery (e.g. 67.7 ± 4.4% knockdown of
As-eft-1 in the tail region at 24 h, P < 0.05)); (c) is consistent and
reproducible (100% success rate across eight targets with differen-
tial expression (see below)); and (d) persists (for up to 8 days; e.g.
98.5 ± 0.4% knockdown of As-eft-1 in the tail region at day 8) (see
Figs. 1 and 2). Our ﬁndings are in contrast to the early literature
describing RNAi susceptibility for some of the veterinary APNs
including Haemonchus contortus, Ostertagia ostertagi and
Teladorsagia circumcincta where hypervariability in the induction
of gene silencing, that appeared to be largely target- and RNAi trig-
ger delivery-dependent, was common (see Maule et al., 2011). One
study has described the development of an RNAi platform for
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delivery approaches across developmental stages and target types
(Zawadzki et al., 2012), providing conﬁdence in the application of
RNAi in this species. In other APNs where inconsistencies were
not highlighted (e.g. for Nippostrongylus brasiliensis, Brugia malayi,
Onchocerca volvulus, Trichostongylus colubriformis, A. suum,
Litmosomoides sigmodontus, Heterorhabditis bacteriophora,
Acanthocheilonema vitea) the majority of studies only targeted
one or two genes (see Maule et al., 2011; Tzelos et al., 2013), mak-
ing it more difﬁcult to assess the reliability of RNAi as a reverse
genetics tool in these species.
(ii) RNAi is capable of spreading in adult A. suum. Our RNAi trig-
ger delivery approach involves the injection of dsRNA into the
pseudocoelomic cavity at a position approximately 1 cm anterior
to the gonopore on the ventral side, where worms were injected
at an angle (approximately 20) to avoid piercing the gut (see
Fig. 1A). We have recorded robust transcript knockdown for ﬁve
targets in tissue segments distant from the site of injection (head
and tail regions; see Figs. 1 and 2; As-eft-1, As-eft-2, As-rab-3,
As-tnc-1, As-gmpr; As-unc-29, As-unc-38), and also in muscle bag
cells (As-unc-29, As-unc-38; see Fig. 3) highlighting the spread of
gene silencing triggers in adult A. suum. Note that the RNAi
response in tissues adjacent to the injection site consistently lags
behind that observed at the worm extremities across all time3
Fig. 1. A novel adult Ascaris suum RNA interference (RNAi) trigger delivery approach indu
delivery approach: double-stranded RNA (dsRNA) was injected anterior to the gonopore a
suum translational elongation factor 1a (As-eft-1) target transcript knockdown was signiﬁ
the RNAi trigger delivery site. Head region: As-eft-1 knockdown in target (As-eft-1) dsRNA
97.6% at 1, 2, 3, 4 and 8 days post-injection, respectively (n = 6 for all time points excep
worms compared with zero dsRNA controls is 64%, 71.7%, 86.5%, 89.6% and 95.7% at 1, 2, 3
target dsRNA treated worms compared with zero dsRNA controls is 67.8%, 86.7%, 94.8%, 9
points except day 4 where n = 4). Note that A. suum elongation factor 1b (As-eft-2) knoc
gonopore: 81.1 ± 10.4% (n = 6; P < 0.05, target dsRNA versus non-target dsRNA); tail: 96.7
eft-1-dsRNA treated worms compared with zero dsRNA control worms, 8 days post-inje
were as follows: (i) dsRNA synthesis. Target and control T7-labelled PCR products (target a
and amplicon sizes were: As-eft-1 (Elongation factor 1a; accession No. BK006061), S 50-G
(Elongation factor 1b; accession No. JI172981) S 50-AATGAACCACCCGGGACAGA-30 , AS
JO467845), S 50-ATCTTTGCGGGCAATGTCGT-30 , AS 50-TGCCCGTTGAGACCATGAGA-30 (185
30 , AS 50-TCCACAGCCGCTTCTAGCTG-30 (192 bp); As-rab-3 (synaptic vesicle pro
TGCACTGTTGTGATGGTGGTTT-30 (195 bp); As-hb-1 (haemoglobin; accession No. AA
(197 bp); As-unc-29 (nicotinic acetylcholine receptor subunit; accession No. ADY42984)
As-unc-38 (nicotinic acetylcholine receptor subunit; accession No. ERG87157), S 50-TG
target control dsRNA (Neomycin Phosphotransferase; accession No. U55762), S 50-GGT
dsRNA T7 template primers had a T7 promoter (50-TAATACGACTCACTATAGGG-30) app
conditions: 95 C  5 min, 40  (95 C  30 s, 60 C  30 s, 72 C  2 min), 72 C  10
www.gatc-biotech.com), and used to synthesise dsRNA with either the MEGAshortscrip
according to manufacturer’s instructions. dsRNA was eluted in Ascaris saline (125 mM C
buffer, pH 6.8), and visualised on a 1.2% agarose gel to conﬁrm integrity. Concentration a
UK). (ii) dsRNA delivery and tissue dissection. Adult female A. suum (P15 cm) were inject
control), into the pseudocoelomic cavity (1 cm anterior to the gonopore on the ventral sid
to facilitate visualisation of pseudocoelomic delivery. Ascaris suum were maintained in A
C4H11NO3/Tris, 99.96 mM NaC2H3O2, 19.64 mM KCl, pH 7.8) for 1–8 days post-injection a
gonopore regions (1 cm segment) were dissected, snap-frozen in liquid nitrogen and sto
layer from a body wall ﬂap (1 cm long; including both dorsal and ventral tissue), that was
submerged in autoclaved Ascaris perienteric ﬂuid (APF: 23 mM NaCl, 110 mM NaC2H3O2,
Sterile scissors were used to snip the arm region of the muscle tissue and release the layer
muscle bag cell layers were dissected from the same body wall ﬂap and processed toget
ﬁne powder whilst frozen using a mortar and pestle. Total RNA was extracted using TRI
Technologies), standardised to 1800 ng/ll, and used for cDNA synthesis (Applied Bios
according to manufacturer’s instructions). Target and reference gene (As-ben-1) transcrip
using a Qiagen Rotor-Gene 5-plex HRM, and FastStart SYBR Green Master (Roche, Switz
follows: As-eft-1, S 50-ATTCTCCGAGACTCGCTTCA-30 , AS 50-GAGATCGGCACGAA
CACGACCCACTGGCACTGTC-30 (94 bp); As-gmpr, S 50-GAGTGGAAGGCTTTCGTG
TCGATGGATCGCAAATCGAA-30 , AS 50-TGGGTGGCCATGATGTAACC-30 (82 bp); As-rab-3, S
hb-1, S 50-GCTTTCAAGGACCGCGAGAA-30 , AS 50-GCAGATGACAGGCGAGCAGA-30 (97 bp);
(95 bp); As-unc-38, S 50-GGCCACTTGCTGATACCGATG-30 , AS 50-GGCTTACGCGATGTTCGTG
CCCACATACGGAGACCTCAACC-30 , AS 50-CCAATTTGCGCAAGTCTGCAT-30 (103 bp); cyclin
x10 min). PCR efﬁciencies were calculated using Real-time PCR Miner (http://www.m
transcript levels by the augmented comparative DDCt method (Pfafﬂ, 2001). Changes in
Wallis test, and the Dunn’s post-test (to assess the signiﬁcance of the zero dsRNA and targ
detect a signiﬁcant difference between zero dsRNA and non-target dsRNA controls in anpoints (see Fig. 1B). The signiﬁcance of the apparent lag is unclear.
The fact that the temporal dynamics of the RNAi responses in the
head, tail, gonopore and somatic muscle are similar enhances the
interpretation of phenotypic readouts, and means that distinct tis-
sues from the same worm can be used for a range of analyses such
as transcript and protein quantitation and physiology/biochemical
assays. This enhances the appeal of A. suum as a model nematode
for reverse genetics.
The observed efﬁciency in adult A. suum RNAi is in contrast to
that described for other APNs (see Maule et al., 2011). It seems
likely that our injection of dsRNA directly into the pseudocoelom
would enhance RNAi trigger delivery and could reduce variability
in RNAi induction compared with that achieved in other APNs
using alternative dsRNA delivery approaches (see Maule et al.,
2011). Large adult worms contain 1 ml of pseudocoelomic ﬂuid
that is continuously circulated within the pseudocoelomic cavity
by the activity of the somatic body wall muscle. This likely enables
the efﬁcient spread of the dsRNA within the pseudocoelomic ﬂuid,
bringing it into close contact with the various organs/tissues of the
worm. This is likely to enhance the efﬁciency of RNAi in terms of
both spread and direct access to cells.
It is interesting to note the absence of sid-1 and sid-2 homo-
logues from A. suum, known to be important for the uptake and
spread of environmental RNAi in nematodes, and the presence ofces a robust systemic RNAi response in distinct tissue regions. (A) Novel RNAi trigger
nd transcript levels were assessed in head, gonopore and tail tissue segments. (B) A.
cant (>95% by day 8, P < 0.05), and persistent (up to 8 days) in tissues remote from
treated worms compared with zero dsRNA controls is 48.8%, 84.4%, 92%, 94.1% and
t day 4 where n = 4); gonopore region: As-eft-1 knockdown in target dsRNA treated
, 4 and 8 days post-injection, respectively (n = 6); tail region: As-eft-1 knockdown in
0.8% and 98.5% at 1, 2, 3, 4 and 8 days post-injection, respectively (n = 6 for all time
kdown (head: 87.7 ± 2.8% (n = 6; P < 0.05, target dsRNA versus non-target dsRNA);
± 1.2% (n = 6; P < 0.05, target dsRNA versus non-target dsRNA)) was assessed in As-
ction (graph not shown); error bars represent S.E.M.; *P < 0.05, **P < 0.01. Methods
nd control GenBank accession numbers, sense (S) and antisense (AS) primers (50-30),
AGGCTCTGTCGCTTCTGAC-30 , AS 50-TTGAGGAACTTCGGGTTGTC-30 (219 bp); As-eft-2
50-TCAACGCACAGCGGTTTTGT-30 (201 bp); As-gmpr (GMP reductase; accession No.
bp); As-tnc-1 (troponin C; accession No. JO472030), S 50-CGACGAGTTTTGCGCTCTTG-
tein; accession No. JI178604), S 50-CCGATCAGCTCGGTTTGGAG-30 , AS 50-
A29374), S 50-TCTTTGCGCCACCTACGATG-30 , AS 50-ACTCCCTGCCGATTTCATGC-30
, S 50-ACTTTCGGGGACCGACCACT-30 , AS 50-GTGATGTGCGGACGGATTCA-30 (209 bp);
GTGGTGTCAGCGTGCTTT-30 , AS 50-TGCTCATCGAATGGAAACCATC-30 (204 bp); non-
GGAGAGGCTATTCGGCT-30 , AS 50-CCTTCCCGCTTCAGTGACAA-30 (223 bp); note that
ended to the 50 end) with sense and antisense polarity were ampliﬁed (cycling
min) from sequence-veriﬁed cDNA templates (GATC Biotech, Germany, http://
t™ Kit (Life Technologies, USA), or T7 RiboMAX™ Express RNAi kit (Promega, USA)
H3COONa, 24.5 mM KCl, 4 mM NaCl, 11.8 mM CaCl2, 9.8 mM MgCl2, 5 mM MOPS
nd purity were assessed using a Nanodrop ND-1000-A spectrophotometer (Labtech,
ed (26 gauge needle) with 100 ll of dsRNA (200 ng/ll) or Ascaris saline (zero dsRNA
e of the worm). dsRNA and Ascaris saline was supplemented with 1% green food dye
scaris Ringer Solution (13.14 mM NaCl, 9.47 mM CaCl2, 7.83 mM MgCl2, 12.09 mM
fter which tissue sections from the head (1.5 cm segment), tail (1.5 cm segment) and
red at 80 C until use. Where relevant, muscle bag cells were dissected as a tissue
excised 2 cm anterior to the gonopore. Post-dissection, muscle bag cell layers were
24 mM KCl, 6 mM CaCl2, 5 mM MgCl2, 11 mM C6H12O6, 5 mM C8H18N2O4S, pH 7.6).
of muscle bag cells from the rest of the body wall. Note that both ventral and dorsal
her. (iii) Post-RNAi transcript analysis. Individual tissue segments were ground to a
zol Reagent (Life Technologies), treated with DNase I (Ambion TURBO DNase, Life
ystems High Capacity RNA-to-cDNA reverse transcription kit (Life Technologies)
ts were ampliﬁed from each cDNA in triplicate by quantitative real-time PCR (qPCR)
erland) (target and reference gene S- and AS primers, and amplicon sizes were as
AGCTAC-30 (99 bp); As-eft-2, S 50-GTCCCACCACAGAGGCCAAC-30 , AS 50-
CAA-30 , AS 50-CCGATGTCGATATTCCCGATG-30 (85 bp); As-tnc-1, S 50-
50-CGCGGGGATAAACGTGTCA-30 , AS 50-GAAGCCCATTGCACCACGAT-30 (105 bp); As-
As-unc-29, S 50-CCCCACTGATTCAGGCGAAA-30 , AS 50-TGGGTGGCAGGATCTTCGAT-30
A-30 (102 bp); As-ben-1 (beta-tubulin; GenBank accession number FE913811), S 50-
g conditions: 9 C  10 min, 40  (95 C  15 s, 60 C  15 5 s, 72 C  30 s), 72 C
iner.ewindup.info/index.htm) and used for relative quantiﬁcation of target gene
target gene transcript abundance were analysed using the non-parametric Kurskal–
et dsRNA treatments against the non-target dsRNA, separately; note that we did not
y dataset) with GraphPad PRISM Version 5 (GraphPad Software, Inc., USA).
Fig. 2. Targets with differential expression patterns are susceptible to RNA interference (RNAi) in adult Ascaris suum, including those restricted to one tissue type. (A–C)
Transcript reduction in a range of target tissues across head (a), gonopore (b) and tail (c) regions 3 days post-injection, including those with: (A) multi-tissue expression: GMP
reductase (As-gmpr) knockdown (Aa) head: 78.5 ± 8.0%; (Ab) gonopore: 60.0 ± 15.7%; (Ac) tail: 96.4 ± 0.1%) in As-gmpr double-stranded RNA (dsRNA)-treated worms
compared with zero dsRNA control worms (n = 6). (B) Neuronal expression: A. suum synaptic vesicle protein (As-rab-3) knockdown (Ba) head: 93.8 ± 2.5%; (Bb) gonopore:
85.4 ± 6.4%; (Bc) tail: 95.2 ± 1.4%) in As-rab-3-dsRNA treated worms compared with zero dsRNA control worms (n = 6); (C) Muscle eExpression: A. suum troponin C (As-tnc-1)
knockdown (Ca) head: 80 ± 7.6%; (Cb) gonopore: 75.6 ± 9.8%; (Cc) tail: 92.1 ± 1.2%) in As-tnc-1-dsRNA-treated worms compared with zero dsRNA control worms (n = 6); in
addition, knockdown was achieved for a gut and body wall expressed target (haemoglobin (As-hb-1; gonopore: 74.2 ± 11.2%; day 3, n = 3; P < 0.05, target dsRNA versus non-
target dsRNA); graph not shown) and two nicotinic acetylcholine receptor subunits expressed in the neuromuscular system (As-unc-29, As-unc-38; see Fig. 3). Error bars
represent S.E.M.; *P < 0.05, **P < 0.01.
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proteins associated with the intercellular spread of RNAi (see
Dalzell et al., 2011). The presence and/or absence of these proteins
clearly does not limit RNAi capability in A. suum as is the case with
other RNAi-competent nematode species which also lack these
proteins (e.g. Meloidogyne incognita and Globodera pallida)
(Dalzell et al., 2011; Cotton et al., 2014). As suggested by Dalzell
et al. (2011), there may be uncharacterised RNAi pathway proteins
that fulﬁl these roles.
(iii) Multiple A. suum tissue-speciﬁc targets are susceptible to
RNAi including ‘neuronal’ genes. We have shown that a range of
targets are susceptible to RNAi in adult A. suum including those
expressed in: multiple tissues (As-eft-1; As-eft-2; As-gmpr); muscle
(As-tnc-1); nerve (As-rab-3); gut/body wall (As-hb-1); and the neu-
romuscular system (As-unc-29, As-unc-38) (based on spatial
expression of homologous genes in Caenorhabditis elegans) (see
Figs. 1–3). Samarasinghe et al. (2011) suggest a correlation
between target accessibility and RNAi susceptibility in that targets
genes that are expressed in tissues accessible to an external source
of dsRNA are more likely to be susceptible to RNAi. Here we do not
see any tissue-speciﬁc differences in our ability to induce RNAi in
adult A. suum. We believe that dsRNA delivery to the pseudocoel
circumvents any potential RNAi trigger accessibility issues. The
physiology of A. suum is such that the pseudocoelomic ﬂuid per-
fuses multiple target tissues including the intestine, muscle (body
wall, pharynx, ovijector, anus), nerve, hypodermis, and systems
associated with reproduction and excretion, and it is therefore anideal vehicle to carry dsRNA cargo to its target, offering a systemic
delivery system.
Signiﬁcantly, we have not noted any neuronal RNAi refractori-
ness that has been observed in other nematode species e.g. C. ele-
gans (Timmons et al., 2001). Here we report signiﬁcant silencing
for three neuronal targets (As-rab-3, As-unc-29 and As-unc-38
(see Figs. 2 and 3)), providing conﬁdence that neuronal targets
are as susceptible to RNAi as those expressed in other tissues.
Until now, successful RNAi of neuronal targets in parasitic nema-
todes has been restricted to the plant parasitic nematodes (see
Maule et al., 2011).
(iv) A multi-target dsRNA cocktail delivery approach is efﬁcient
in inducing RNAi. Here we demonstrate that effective gene silenc-
ing is achievable when two dsRNA species, targeting different tran-
scripts (e.g. As-unc-29 and As-unc-38) are delivered as a cocktail
(Fig. 3). This is signiﬁcant with respect to experimental set up as
it reduces time, cost and worm/tissue requirements. In addition,
from a gene function perspective, this approach enables the
co-silencing of multiple related genes where functional redun-
dancy may be a concern, but promiscuous dsRNA design is not pos-
sible. It will be interesting to determine the limitations of this
approach with respect to RNAi efﬁciency, and to assess the efﬁcacy
of small interfering RNA (siRNA)-mediated RNAi in A. suum.
(v) RNAi is consistent across geographical isolates of A. suum.
Here we present data to show that A. suum from different geo-
graphical regions were equally susceptible to RNAi (Fig. 3), and
that there was no signiﬁcant difference in the dynamics associated
Fig. 3. RNA interference (RNAi) is achievable using a ‘multi-target dsRNA cocktail’
delivery approach and in different geographical isolates of Ascaris suum. (A) Two
nicotinic acetylcholine receptor subunits, As-unc-29 and As-unc-38, transcript
knockdown (8 days post injection) in gonopore-tissue segments of adult A. suum
collected in Ballymena, Northern Ireland (European Isolate: As-unc-29 knockdown
in target dsRNA-treated worms compared with zero dsRNA controls is 92.9 ± 1.8%
(n = 6); As-unc-38 knockdown in target dsRNA-treated worms compared with zero
dsRNA controls is 83.9 ± 3.3% (n = 6)). (B) As-unc-29 and As-unc-38 transcript
knockdown (8 days post-injection) in gonopore tissue segments of adult A. suum
collected in Marshalltown, Iowa, U.S.A. (North American Isolate: As-unc-29 knock-
down in target dsRNA-treated worms compared with zero dsRNA controls is
84.2 ± 3.4% (n = 6); As-unc-38 knockdown in target dsRNA-treated worms compared
with zero dsRNA controls is 77.1 ± 4.5% (n = 6)). Note that transcript knockdown
was also assessed in the head region (European isolate only: As-unc-29 knockdown
in target dsRNA-treated worms compared with zero dsRNA controls is 86.3 ± 7.7%
(n = 5); P < 0.05, target dsRNA versus non-target dsRNA; As-unc-38 knockdown in
target dsRNA-treated worms compared with zero dsRNA controls is 83.9 ± 7.4%
(n = 5); P < 0.05, target dsRNA versus non-target dsRNA; graphs not shown), and
muscle bag cells (North American isolate only: As-unc-29 knockdown in target
dsRNA-treated worms compared with zero dsRNA controls is 82.2 ± 6.2% (n = 6);
P < 0.05, target dsRNA versus non-target dsRNA; As-unc-38 knockdown in target
dsRNA-treated worms compared with zero dsRNA controls is 85.6 ± 3.8% (n = 6);
P < 0.05, target dsRNA versus non-target dsRNA; graphs not shown). Error bars
represent S.E.M; *P < 0.05, **P < 0.01. Note that in all cases target dsRNA-treated
worms were injected with a cocktail of dsRNA-As-unc-29 and dsRNA-As-unc-38.
C.J. McCoy et al. / International Journal for Parasitology 45 (2015) 673–678 677with the induction of knockdown across geographical isolates.
These data are signiﬁcant given that different strains of C. elegans
appear to be variably susceptible to somatic RNAi (Félix et al.,
2011), and emphasise the potential intercontinental utility of
RNAi in adult A. suum, supporting its widespread application.
We believe that this study is the ﬁrst report of successful gene
silencing in adult A. suum. We have shown that RNAi is achievable
across multiple targets and tissues and present a novel, efﬁcient
RNAi delivery approach. The appeal of the A. suum RNAi platformdescribed here is enhanced by the unique experimental tractability
of the adult worm and the availability of a number of post-RNAi
functional bioassays at the whole worm (body waveform, egg out-
put, development), tissue (body wall muscle, pharynx, ovijector)
and cell (muscle and neuron electrophysiology) levels (see
Pecson et al., 2006; Stretton and Maule, 2013). This provides an
appealing platform for the identiﬁcation and validation of drug tar-
gets in parasitic nematodes of veterinary and human importance.
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